Department of Public Health, University of Helsinki, Helsinki, Finland.
Diabetes Metab Res Rev. 2010 May;26(4):245-53. doi: 10.1002/dmrr.1078.
Age is associated with both impaired glucose and insulin metabolism. To what extent the age-related changes in insulin resistance (IR) and beta-cell function contribute to the increase in prevalence of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) is less known, and this is investigated in this study.
This study included 6610 men and 7664 women of different ethnic groups aged 30-69 years. IR and beta-cell function were examined by the homeostasis model assessment of insulin resistance (HOMA-IR) and homeostasis model assessment of beta-cell function (HOMA-B). Odds ratios (ORs) and 95% confidence intervals (95% CIs) were estimated using logistic regression analysis adjusting for body mass index and study.
In Chinese men, the ORs (95% CIs) for IFG were 2.69 (1.70, 4.26), 2.51 (1.49, 4.21) and 2.89 (1.68, 4.97), respectively, in age groups of 40-49, 50-59 and 60-69 years compared with 30-39 years (p < 0.001 for trend); the corresponding figures for IGT were 1.73 (1.25, 2.38), 2.54 (1.78, 3.63) and 3.57 (2.46, 5.19) (p < 0.001 for trend). Similar trends for IGT were observed also in Chinese women and other ethnic groups, but not for IFG in Mauritius Indian and Creole men. Adjustment for HOMA-IR and HOMA-B reduced the ORs in all age groups of all ethnicities for both IFG and IGT, but the risk gradient between age groups remained particularly for the IGT.
The age-related increase in glucose intolerance may not be fully explained by the defect in HOMA-IR and HOMA-B. As HOMA-IR and HOMA-B are only surrogate measures of insulin sensitivity and insulin secretion, the results need to be further investigated.
年龄与葡萄糖和胰岛素代谢受损有关。年龄相关的胰岛素抵抗(IR)和β细胞功能的变化在多大程度上导致空腹血糖受损(IFG)和葡萄糖耐量受损(IGT)的患病率增加尚不清楚,本研究对此进行了调查。
本研究纳入了来自不同种族的 6610 名男性和 7664 名女性,年龄在 30-69 岁之间。通过稳态模型评估的胰岛素抵抗(HOMA-IR)和β细胞功能(HOMA-B)来检测 IR 和β细胞功能。使用 logistic 回归分析调整体重指数和研究后,估计比值比(ORs)和 95%置信区间(95%CI)。
在中国男性中,与 30-39 岁年龄组相比,40-49 岁、50-59 岁和 60-69 岁年龄组的 IFG 的 OR(95%CI)分别为 2.69(1.70,4.26)、2.51(1.49,4.21)和 2.89(1.68,4.97)(p<0.001 趋势);IGT 的相应数值为 1.73(1.25,2.38)、2.54(1.78,3.63)和 3.57(2.46,5.19)(p<0.001 趋势)。在其他种族中也观察到了类似的 IGT 趋势,但在毛里求斯印度和克里奥尔男性中,IFG 并未出现这种趋势。在所有种族的所有年龄组中,调整 HOMA-IR 和 HOMA-B 均降低了 IFG 和 IGT 的 OR,但年龄组之间的风险梯度仍然存在,尤其是对于 IGT。
葡萄糖耐量受损的年龄相关性增加可能无法完全用 HOMA-IR 和 HOMA-B 的缺陷来解释。由于 HOMA-IR 和 HOMA-B 只是胰岛素敏感性和胰岛素分泌的替代测量指标,因此需要进一步研究这些结果。